Michaela Reissland
Has participated in:
-
USP10 is a de novo tumour-specific regulator of β-Catenin and contributes to cancer stem cell maintenance and tumour progression
-
Implementation of CRISPR/Cas9 Genome Editing to Generate Murine Lung Cancer Models That Depict the Mutational Landscape of Human Disease
-
RNF4~RGMb~BMP6 axis required for osteogenic differentiation and cancer cell survival
-
Maintaining protein stability of ∆Np63 via USP28 is required by squamous cancer cells